Showing results (41-50 of 99) with videos related to

Sort By:
Pageof 10
Italian Heart Journal : Official Journal of the Italian Federation of Cardiology|June 18, 2002
Metabolic disorders and cardiovascular risk in HIV-infected patients treated with antiretroviral agentsMassimo Fantoni, Cosmo Del Borgo, Camillo Autore, et al.
Current Pharmaceutical Design|October 5, 2006
Phosphodiesterase 5 inhibitors--drug design and differentiation based on selectivity, pharmacokinetic and efficacy profilesClaudiu T Supuran, Antonio Mastrolorenzo, Giuseppe Barbaro, et al.
Virology Journal|December 18, 2013
Naturally occurring resistance mutations to inhibitors of HCV NS5A region and NS5B polymerase in DAA treatment-naïve patientsStefania Paolucci, Loretta Fiorina, Bianca Mariani, et al.
Current Pharmaceutical Design|July 17, 2010
Diagnosis and prognosis of fetal cardiomyopathies: a reviewMaurizio Mongiovì, Vlasta Fesslova, Giovanni Fazio, et al.
Obesity (Silver Spring, Md.)|April 2, 2008
Threshold values of high-risk echocardiographic epicardial fat thicknessGianluca Iacobellis, Howard J Willens, Giuseppe Barbaro, et al.
Current Pharmaceutical Design|November 11, 2008
Cardiac metabolism in myocardial ischemiaGiuseppe M C Rosano, Massimo Fini, Giuseppe Caminiti, et al.
BMC Gastroenterology|November 20, 2012
HCV genotype 1a shows a better virological response to antiviral therapy than HCV genotype 1bAdriano M Pellicelli, Mario Romano, Tommaso Stroffolini, et al.
Current Pharmaceutical Design|November 11, 2008
The role of statins in preventing the progression of congestive heart failure in patients with metabolic syndromeGiovanni Fazio, Gisella Rita Amoroso, Giuseppe Barbaro, et al.
Pageof 10